FDA Gives 'Tentative' Approval to Abuse-Deterrent Xtampza ERFDA Gives 'Tentative' Approval to Abuse-Deterrent Xtampza ER

Final approval of the extended-release chronic pain medication is pending the outcome of patent litigation, the company reports. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news